Business / Finance

RSS

Ventana partners with Incyte to develop companion diagnostic tests for oncology drug programs

Ventana Medical Systems, Inc., a member of the Roche Group, today announced that it has entered into an agreement with Incyte Corporation to collaborate on the development of companion diagnostic tests for Incyte's oncology drug programs, beginning with the Incyte IDO1 inhibitor program.

5 Nov 2013

Life Technologies revenue for third quarter increases 3% to $936

Life Technologies Corporation (NASDAQ: LIFE) today announced results for its third quarter ended September 30, 2013. Revenue for the third quarter was $936 million, an increase of 3 percent over the $911 million reported for the third quarter of 2012.

5 Nov 2013

HighPoint Solutions, AssurX announce formalization of ongoing strategic partnership

HighPoint Solutions, LLC, a premier, global provider of specialized IT services dedicated to the life sciences and healthcare industries, and AssurX, Inc., a leading Enterprise Quality Management and Regulatory Compliance Software company, are announcing the formalization of their ongoing strategic partnership.

5 Nov 2013

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced third quarter 2013 financial results.

5 Nov 2013

BioMed Realty Trust's total revenues up by 18.4% in third quarter 2013

BioMed Realty Trust, Inc., the leading provider of real estate to the life science industry, today announced financial results for the third quarter ended September 30, 2013.

5 Nov 2013

Medifast net revenue decreases 5% to $86.5 million in Q3 2013

Medifast, Inc., a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today reported financial results for the third quarter ended September 30, 2013.

5 Nov 2013

Mesa Laboratories second quarter 2013 revenues up 8%

Mesa Laboratories, Inc. today reported an eight percent increase in revenues for the second quarter ended September 30, 2013.

5 Nov 2013

Gentiva Health Services third quarter 2013 net revenues decrease 3.3% to $410.5 million

Gentiva Health Services, Inc., the largest provider of home health and hospice services in the United States based on revenue, today reported third quarter 2013 results.

5 Nov 2013

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

Zevacor Molecular, an independently owned healthcare firm that manufactures and distributes PET and SPECT radiopharmaceuticals, has purchased the first 70 MeV Cyclotron dedicated to medical use in the United States from Ion Beam Applications, S.A.

5 Nov 2013

Liaison Healthcare forms strategic partnership with PointClickCare

Liaison Healthcare, a global provider of secure cloud-based integration and data management services and solutions, announced today a strategic partnership with PointClickCare, the most widely used Electronic Health Record platform for the long-term care industry, connecting their EHR platform to more than 120 labs and imaging departments already integrated within the Liaison EMR-Link hub, as well as others that provide specific services to the long term care community.

4 Nov 2013

USPI net revenues increase 17.7% to $151 million in third quarter 2013

United Surgical Partners International, Inc. today announced results for the third quarter and nine months ended September 30, 2013.

4 Nov 2013

Can-Fite BioPharma executes confidentiality agreements for commercialization of CF101 drug

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it executed confidentiality agreements with 10 established pharmaceutical and biotechnology companies with respect to potential negotiations for the commercialization of CF101 for the treatment of autoimmune inflammatory indications.

4 Nov 2013

JDRF partners with Pfizer's CTI to support diabetes research

JDRF, the leading global organization funding type 1 diabetes research, announced today a partnership with Pfizer's Centers for Therapeutic Innovation to support the development and translation of promising diabetes research.

4 Nov 2013

Covalon licenses antimicrobial silicone adhesive technology to Molnlycke Heath Care

Covalon Technologies Ltd., an advanced medical technologies company, today announced that it has licensed its antimicrobial silicone adhesive technology to Molnlycke Heath Care.

4 Nov 2013

NeuroSky forms strategic partnership with SoftBank Mobile to improve health and wellness

NeuroSky, a global leader in body and mind monitoring and analysis technologies, today announced that is has secured a significant investment from SoftBank Corp. to form a strategic partnership with SoftBank Mobile Corp.

4 Nov 2013

RaySearch Laboratories, Hitachi sign long-term distribution agreement

RaySearch Laboratories AB has entered into a long-term distribution agreement with Hitachi Medical Corporation based in Tokyo, Japan. The agreement means that Hitachi will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation® on the Japanese market from April 1, 2014.

4 Nov 2013

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

Polyphor Ltd, a privately held pharmaceutical company, and Roche announced today that they have entered into an exclusive worldwide license agreement to develop and commercialize Polyphor's investigational macrocycle antibiotic, POL7080, for patients suffering from bacterial infections caused by Pseudomonas aeruginosa.

4 Nov 2013

Avidus Management Group provides market guidance relating to acquisition strategy

Avidus Management Group Inc. ("Avidus" or the "Company"), today provided market guidance relating to its acquisition strategy.

31 Oct 2013

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Crown serves pharmaceutical companies and biotech companies. We have two areas of focus: oncology and metabolic diseases. In the oncology space we focus on pre-clinical services. Essentially, we have all the tools to help our customers move from target discovery, target validation, to a clinical candidate.

31 Oct 2013

Cardinal Health's non-GAAP operating earnings increase 13% to $532M in Q1 FY 2014

Cardinal Health today reported fiscal year 2014 first-quarter revenue of $24.5 billion and a 36 percent increase in non-GAAP diluted earnings per share (EPS) from continuing operations to $1.10. Non-GAAP operating earnings increased 13 percent to $532 million.

31 Oct 2013

Business / Finance

Ventana partners with Incyte to develop companion diagnostic tests for oncology drug programs

Life Technologies revenue for third quarter increases 3% to $936

HighPoint Solutions, AssurX announce formalization of ongoing strategic partnership

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

BioMed Realty Trust's total revenues up by 18.4% in third quarter 2013

Medifast net revenue decreases 5% to $86.5 million in Q3 2013

Mesa Laboratories second quarter 2013 revenues up 8%

Gentiva Health Services third quarter 2013 net revenues decrease 3.3% to $410.5 million

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

Liaison Healthcare forms strategic partnership with PointClickCare

USPI net revenues increase 17.7% to $151 million in third quarter 2013

Can-Fite BioPharma executes confidentiality agreements for commercialization of CF101 drug

JDRF partners with Pfizer's CTI to support diabetes research

Covalon licenses antimicrobial silicone adhesive technology to Molnlycke Heath Care

NeuroSky forms strategic partnership with SoftBank Mobile to improve health and wellness

RaySearch Laboratories, Hitachi sign long-term distribution agreement

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

Avidus Management Group provides market guidance relating to acquisition strategy

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Cardinal Health's non-GAAP operating earnings increase 13% to $532M in Q1 FY 2014

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News